PrairieView Partners’s Boston Scientific BSX Stock Holding History

PrairieView Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$48K	Hold	448	–	–	﹤0.01%	190
2025 Q1	$45K	Hold	448	–	–	﹤0.01%	198
2024 Q4	$40K	Hold	448	–	–	﹤0.01%	209
2024 Q3	$37K	Hold	448	–	–	﹤0.01%	213
2024 Q2	$34K	Hold	448	–	–	﹤0.01%	227
2024 Q1	$31K	Hold	448	–	–	﹤0.01%	215
2023 Q4	$26K	Hold	448	–	–	﹤0.01%	219
2023 Q3	$23K	Hold	448	–	–	﹤0.01%	229
2023 Q2	$24K	Buy	+448	New	+$23.4K	﹤0.01%	253
2020 Q4	–	Sell	-300	Closed	-$11K	–	312
2020 Q3	$11K	Hold	300	–	–	﹤0.01%	233
2020 Q2	$11K	Hold	300	–	–	﹤0.01%	230
2020 Q1	$10K	Buy	+300	New	+$11.7K	﹤0.01%	219

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PrairieView Partners's BSX Position: Q2 2025 in Review

PrairieView Partners held its Boston Scientific (BSX) position steady in Q2 2025 at 448 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #190.

PrairieView Partners first reported a position in BSX in Q1 2020 and has held it in 12 quarters since. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

PrairieView Partners held 448 shares of Boston Scientific worth $48K as of Q2 2025.
PrairieView Partners left its Boston Scientific share count unchanged in Q2 2025.
Boston Scientific made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #190 holding.
PrairieView Partners first reported a position in Boston Scientific in Q1 2020 and has held it in 12 quarters since.
1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.